Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Surgery Today
Published in: Surgery Today 5/2018

Open Access 01-05-2018 | Original Article

Laparoscopic surgery for locally advanced T4 colon cancer: the long-term outcomes and prognostic factors

Authors: Takahiro Yamanashi, Takatoshi Nakamura, Takeo Sato, Masanori Naito, Hirohisa Miura, Atsuko Tsutsui, Masashi Shimazu, Masahiko Watanabe

Published in: Surgery Today | Issue 5/2018

Login to get access

Abstract

Purpose

For locally advanced pathological T4 (pT4) colon cancer, the safety and feasibility of laparoscopic procedures remain controversial. Therefore, this study aimed to assess short-term and long-term outcomes and to identify the prognostic factors in laparoscopic surgery for pT4 colon cancer.

Methods

The study group included 130 patients who underwent laparoscopic radical resection for pT4 colon and rectosigmoid cancer from January 2004 through December 2012. The short-term outcomes, long-term outcomes, and prognostic factors in pT4 colon cancer were analyzed.

Results

The median operative time was 205 min, with a median blood loss of 10 ml. The conversion rate was 3.8%, and 13 patients (10.0%) had postoperative complications. The radial resection margin was positive in 1 patient (0.8%). The median follow-up time was 73 months. The 5-year overall survival (OS) and recurrence-free survival (RFS) were 77.2 and 63.5%, respectively. On a multivariate analysis, a male sex [hazard ratio (HR) 3.09, p < 0.001], lymph node ratio ≥ 0.06 (HR 2.35, p = 0.021), tumor diameter < 38 mm (HR 2.57, p = 0.007), and right-sided colon cancer (HR 2.11, p = 0.047) were significantly related to a poor OS.

Conclusions

These results suggest that laparoscopic surgery for pT4 colon cancer is safe and feasible, and the oncological outcomes are acceptable. Based on the present findings, select patients with locally advanced colon cancer should not be excluded from laparoscopic surgery.
Literature
1.
Lacy AM, García-Valdecasas JC, Delgado S, Castells A, Taurá P, Piqué JM, et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet. 2002;359:2224–9.CrossRefPubMed
2.
Nelson H, Sargent DJ, Wieand HS, Fleshman J, Anvari M, Stryker SJ, et al. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004;350:2050–9.CrossRefPubMed
3.
Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AMH, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365:1718–26.CrossRefPubMed
4.
Veldkamp R, Kuhry E, Hop WC, Jeekel J, Kazemier G, Bonjer HJ, et al. Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol 2005;6:477–84.CrossRefPubMed
5.
Fleshman J, Sargent DJ, Green E, Anvari M, Stryker SJ, Beart RW Jr, et al. Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. Ann Surg 2007;246:655–62 (discussion 62–4).CrossRefPubMed
6.
Buunen M, Veldkamp R, Hop WC, Kuhry E, Jeekel J, Haglind E, et al. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol. 2009;10:44–52.CrossRefPubMed
7.
Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg. 2010;97:1638–45.CrossRefPubMed
8.
Yamamoto S, Inomata M, Katayama H, Mizusawa J, Etoh T, Konishi F, et al. Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open D3 dissection for stage II/III colon cancer: Japan Clinical Oncology Group Study JCOG 0404. Ann Surg. 2014;260:23–30.CrossRefPubMed
9.
Matsumoto S, Bito S, Fujii S, Inomata M, Saida Y, Murata K, et al. Prospective study of patient satisfaction and postoperative quality of life after laparoscopic colectomy in Japan. Asian J Endosc Surg 2016;9:186–91.CrossRefPubMed
10.
Kitano S, Inomata M, Mizusawa J, Katayama H, Watanabe M, Yamamoto S, et al. Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial. Lancet Gastroenterol Hepatol. 2017;2:261–8.CrossRefPubMed
11.
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471–4.CrossRefPubMed
12.
Nakafusa Y, Tanaka T, Tanaka M, Kitajima Y, Sato S, Miyazaki K. Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome. Dis Colon Rectum. 2004;47:2055–63.CrossRefPubMed
13.
Mohan HM, Evans MD, Larkin JO, Beynon J, Winter DC. Multivisceral resection in colorectal cancer: a systematic review. Ann Surg Oncol. 2013;20:2929–36.CrossRefPubMed
14.
Bretagnol F, Dedieu A, Zappa M, Guedj N, Ferron M, Panis Y. T4 colorectal cancer: is laparoscopic resection contraindicated?. Colorect Dis 2011;13:138–43.CrossRef
15.
Ng DC, Co CS, Cheung HY, Chung CC, Li MK. The outcome of laparoscopic colorectal resection in T4 cancer. Colorect Dis. 2011;13:e349–e52.CrossRef
16.
Huh JW, Kim HR. The feasibility of laparoscopic resection compared to open surgery in clinically suspected T4 colorectal cancer. J Laparoendosc Adv Surg Tech A. 2012;22:463–7.CrossRefPubMed
17.
Kim KY, Hwang DW, Park YK, Lee HS. A single surgeon’s experience with 54 consecutive cases of multivisceral resection for locally advanced primary colorectal cancer: can the laparoscopic approach be performed safely? Surg Endosc. 2012;26:493–500.CrossRefPubMed
18.
Vignali A, Ghirardelli L, Di Palo S, Orsenigo E, Staudacher C. Laparoscopic treatment of advanced colonic cancer: a case-matched control with open surgery. Colorect Dis. 2013;15:944–8.CrossRef
19.
Shukla PJ, Trencheva K, Merchant C, Maggiori L, Michelassi F, Sonoda T, et al. Laparoscopic resection of T4 colon cancers: is it feasible? Dis Colon Rectum. 2015;58:25–31.CrossRefPubMed
20.
de’Angelis N, Vitali GC, Brunetti F, Wassmer CH, Gagniere C, Puppa G, et al. Laparoscopic vs. open surgery for T4 colon cancer: a propensity score analysis. Int J Colorect Dis. 2016;31:1785–97.CrossRef
21.
Kim IY, Kim BR, Kim YW. The short-term and oncologic outcomes of laparoscopic versus open surgery for T4 colon cancer. Surg Endosc. 2016;30:1508–18.CrossRefPubMed
22.
Chan DK, Tan KK. Laparoscopic surgery should be considered in T4 colon cancer. Int J Colorect Dis 2017;32:517–20.CrossRef
23.
Moug SJ, Saldanha JD, McGregor JR, Balsitis M, Diament RH. Positive lymph node retrieval ratio optimises patient staging in colorectal cancer. Br J Cancer. 2009;100:1530–3.CrossRefPubMedPubMedCentral
24.
Ceelen W, Van Nieuwenhove Y, Pattyn P. Prognostic value of the lymph node ratio in stage III colorectal cancer: a systematic review. Ann Surg Oncol. 2010;17:2847–55.CrossRefPubMed
25.
Rosenberg R, Engel J, Bruns C, Heitland W, Hermes N, Jauch KW, et al. The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients. Ann Surg. 2010;251:1070–8.CrossRefPubMed
26.
Greenberg R, Itah R, Ghinea R, Sacham-Shmueli E, Inbar R, Avital S. Metastatic lymph node ratio (LNR) as a prognostic variable in colorectal cancer patients undergoing laparoscopic resection. Tech Coloproctol. 2011;15:273–9.CrossRefPubMed
27.
Greene FL, Stewart AK, Norton HJ. A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg 2002;236:416–21 (discussion 21).CrossRefPubMedPubMedCentral
28.
Shirouzu K, Isomoto H, Kakegawa T, Morimatsu M. A prospective clinicopathologic study of venous invasion in colorectal cancer. Am J Surg 1991;162:216–22.CrossRefPubMed
29.
Dindo D, Demartines N, Clavien PA Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205–13.CrossRefPubMedPubMedCentral
30.
Veldkamp R, Gholghesaei M, Bonjer HJ, Meijer DW, Buunen M, Jeekel J, et al. Laparoscopic resection of colon Cancer: consensus of the European Association of Endoscopic Surgery (EAES). Surg Endosc. 2004;18:1163–85.CrossRefPubMed
31.
Elnahas A, Sunil S, Jackson TD, Okrainec A, Quereshy FA. Laparoscopic versus open surgery for T4 colon cancer: evaluation of margin status. Surg Endosc. 2016;30:1491–6.CrossRefPubMed
32.
33.
Marusch F, Gastinger I, Schneider C, Scheidbach H, Konradt J, Bruch HP, et al. Experience as a factor influencing the indications for laparoscopic colorectal surgery and the results. Surg Endosc 2001;15:116–20.CrossRefPubMed
34.
Miyake Y, Nishimura J, Takahashi H, Haraguchi N, Hata T, Takemasa I, et al. The short-term outcomes of laparoscopic multivisceral resection for locally advanced colorectal cancer: our experience of 39 cases. Surg Today 2017;47:575–80.CrossRefPubMed
35.
National Comprehensive Cancer Network. Principles of pathologic review. Clinical Practice Guidelines in Oncology, Colon and Rectal Cancer, 2009, pp. 1–4. National Comprehensive Cancer Network, Fort Washington, MD.
36.
Ishiguro S, Akasu T, Fujita S, Yamamoto S, Kusters M, Moriya Y. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period. Surgery 2009;145:189–95.CrossRefPubMed
37.
Snaebjornsson P, Coupe VM, Jonasson L, Meijer GA, van Grieken NC, Jonasson JG. pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd’s local peritoneal involvement revisited. Int J Cancer 2014;135:467–78.CrossRefPubMed
38.
Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF. Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomark Prev. 2011;20:1629–37.CrossRef
39.
McArdle CS, McMillan DC, Hole DJ. Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg. 2003;90:711–5.CrossRefPubMed
40.
Paulson EC, Wirtalla C, Armstrong K, Mahmoud NN. Gender influences treatment and survival in colorectal cancer surgery. Dis Colon Rectum. 2009;52:1982–91.CrossRefPubMed
41.
McMillan DC, Wotherspoon HA, Fearon KC, Sturgeon C, Cooke TG, McArdle CS. A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 1995;170:319–22.CrossRefPubMed
42.
Wichmann MW, Zellweger R, DeMaso CM, Ayala A, Chaudry IH. Mechanism of immunosuppression in males following trauma-hemorrhage. Critical role of testosterone. Arch Surg. 1996;131:1186–91 (discussion 91–2).CrossRefPubMed
43.
Wichmann MW, Ayala A, Chaudry IH. Male sex steroids are responsible for depressing macrophage immune function after trauma-hemorrhage. Am J Physiol. 1997;273::C1335–C40.CrossRef
44.
Kornprat P, Pollheimer MJ, Lindtner RA, Schlemmer A, Rehak P, Langner C. Value of tumor size as a prognostic variable in colorectal cancer: a critical reappraisal. Am J Clin Oncol 2011;34:43–9.CrossRefPubMed
45.
Wang Y, Zhuo C, Shi D, Zheng H, Xu Y, Gu W, et al. Unfavorable effect of small tumor size on cause-specific survival in stage IIA colon cancer, a SEER-based study. Int J Colorect Dis. 2015;30:131–7.CrossRef
46.
Takahashi T, Kato T, Kodaira S, Koyama Y, Sakabe T, Tominaga T, et al. Prognostic factors of colorectal cancer. Results of multivariate analysis of curative resection cases with or without adjuvant chemotherapy. Am J Clin Oncol 1996;19:408–15.CrossRefPubMed
47.
Wo JY, Chen K, Neville BA, Lin NU, Punglia RS. Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer. J Clin Oncol. 2011;29:2619–27.CrossRefPubMedPubMedCentral
Metadata
Title
Laparoscopic surgery for locally advanced T4 colon cancer: the long-term outcomes and prognostic factors
Authors
Takahiro Yamanashi
Takatoshi Nakamura
Takeo Sato
Masanori Naito
Hirohisa Miura
Atsuko Tsutsui
Masashi Shimazu
Masahiko Watanabe
Publication date
01-05-2018
Publisher
Springer Singapore
Published in
Surgery Today / Issue 5/2018
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-017-1621-8

Other articles of this Issue 5/2018

Surgery Today 5/2018 Go to the issue

Original Article

Incidence and treatment of metachronous gastric cancer after proximal gastrectomy

Original Article

Correlation between the skeletal muscle index and surgical outcomes of pancreaticoduodenectomy

Original Article

The preoperative HbA1c level is an independent prognostic factor for the postoperative survival after resection of non-small cell lung cancer in elderly patients

Review Article

Spinal cord injury as a complication of thoracic endovascular aneurysm repair

Original Article

Nectin-1 expression in cancer-associated fibroblasts is a predictor of poor prognosis for pancreatic ductal adenocarcinoma

Original Article

Laparoscopic subtotal gastrectomy in morbid obese patients: a valid option to laparoscopic gastric bypass in particular circumstances (prospective study)